Comments on: GENESEEQ RECEIVES CHINESE NMPA APPROVAL FOR LUNG CANCER TUMOR MUTATIONAL BURDEN NGS TEST KIT /geneseeq-receives-chinese-nmpa-approval-for-lung-cancer-tumor-mutational-burden-ngs-test-kit/ We see precision medicine as the future of cancer care. Let’s accelerate precision cancer care, together. Fri, 13 Oct 2023 11:48:18 +0000 hourly 1 https://wordpress.org/?v=6.9.4